- Nachrichtendetail
-
28.05.2024 13:41:17 - dpa-AFX: *JOHNSON & JOHNSON TO ACQUIRE CLINICAL-STAGE BISPECIFIC FOR ATOPIC DERMATITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 146,120 | 02.07.24 19:52:25 | -0,320 | -0,22% | 146,120 | 146,130 | 146,430 | 146,440 |
